Results 241 to 250 of about 14,065,915 (293)

Woodchuck and deer Hepatitis Delta-like agents show distinct innate immune activation and IFN-resistance compared to human Hepatitis D Virus. [PDF]

Sci Rep
Gnouamozi GE, Kooij AC, Schrimpf MR, Zehnder B, Zhang Z, Urban S.   +5 more
europepmc   +1 more source

Impact of Handling Perception and Language Barriers on Virologic Response to Daily Subcutaneous Bulevirtide in Hepatitis D. [PDF]

Liver Int
Herta T, Dietz-Fricke C, Demir M, Sprinzl K, Pfeiffer KH, Grottenthaler JM, Buggisch P, Kremer WM, Reiter FP, Geier A, Schramm C, Merle U, Neumann-Haefelin C, Tacke F, Berg T, Wedemeyer H, Deterding K, Wiegand J.   +17 more
europepmc   +1 more source

Chronic hepatitis D in Austria: high burden of cirrhosis and portal hypertension, IL28B C/C as unfavorable factor, increased systemic inflammation in decompensation. [PDF]

Wien Klin Wochenschr
Schwarz M, Schwarz C, Bauer DJM, Panzer M, Hintersteininger M, Strasser M, Reiter S, Dorn L, Trauner M, Stättermayer AF, Mandorfer M, Maieron A, Moschen A, Aigner E, Zoller H, Gschwantler M, Reiberger T, Jachs M.   +17 more
europepmc   +1 more source

Long-Term Post-transplant Outcomes in Patients with Hepatitis D Virus Infection at a High-Volume Liver Transplant Center. [PDF]

Dig Dis Sci
Keser MF, Keser ZB, Yurdaydin C, Yilmaz S, Harputluoglu M.   +4 more
europepmc   +1 more source

Carcinogenicity of hepatitis D virus, human cytomegalovirus, and Merkel cell polyomavirus. [PDF]

Lancet Oncol
Karagas MR, Kaldor J, Michaelis M, Muchengeti MM, Alfaiate D, Argirion I, Chen X, Cunha C, Hantz S, Koljonen V, Laude HC, Lui WO, Nevels MM, O'Brien TR, Scheurer ME, Touze A, Wiemels JL, Benbrahim-Tallaa L, de Conti A, Facchin C, Madia F, Pasqual E, Wedekind R, Aguilera-Buenosvinos I, Clifford G, Deng X, Dongoran RA, Ezzemni S, Huang Y, Suonio E, Zhai Y, Mattock H, Schubauer-Berigan MK, Kunzmann AT.   +33 more
europepmc   +1 more source

A universal point-of-care immunochromatographic test for the serodiagnosis of hepatitis D. [PDF]

J Clin Microbiol
Lopes TB, Coelho FF, Roca TP, Oliveira JKA, Delagarde V, Brichler S, Gómez Mendoza DP, Villalobos Salcedo JM, Vieira DS, Le Gal F, Gazzinelli RT, Fernandes AP.   +11 more
europepmc   +1 more source

Correction to: Hepatitis D Virus Seroconversion Rate Among People With Chronic Hepatitis B Virus Infection in France and The Gambia (Inci-D). [PDF]

Open Forum Infect Dis
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Hepatitis D

JAMA, 2023
ImportanceHepatitis D virus (HDV) infection occurs in association with hepatitis B virus (HBV) infection and affects approximately 12 million to 72 million people worldwide. HDV causes more rapid progression to cirrhosis and higher rates of hepatocellular carcinoma than HBV alone or hepatitis C virus.ObservationsHDV requires HBV to enter hepatocytes ...
Francesco, Negro, Anna S, Lok
  +5 more sources

Hepatitis D

Current Treatment Options in Gastroenterology, 2007
The hepatitis delta virus (HDV) is a defective RNA virus that requires the help of hepatitis B virus (HBV) for virion assembly and penetration into hepatocytes. Thus, it can only cause disease in individuals who carry HBV. HDV infection is present worldwide, predominantly in tropical and subtropical areas.
Elif S, Koytak, Cihan, Yurdaydin, Jeffrey S, Glenn   +2 more
openaire   +2 more sources